Esperion Thera

ESPR NASDAQ
51.31
+2.14
+4.35%
已收盘, 16:48 06/17 EDT
开盘
49.57
昨收
49.17
最高
51.65
最低
49.16
成交量
56.59万
成交均量(3M)
58.13万
52周最高
60.99
52周最低
36.06
换手率
2.10%
市值
13.81亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Esperion Thera ESPR股票价格,Esperion Thera股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company's lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy.
展开 >

最近浏览

名称
价格
涨跌幅